Kajal Larson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 11
-
- Liver Disease Diagnosis and Treatment 2
- Urinary Tract Infections Management 2
- Co-authors
- Edward P. Acosta (5 shared papers)Elizabeth G. Rhee (9 shared papers)Luzelena Caro (7 shared papers)Adedayo Adedoyin (4 shared papers)Matthew L. Rizk (7 shared papers)Brian Yu (6 shared papers)Yoshihiko Murata (2 shared papers)Laurent Chesnel (2 shared papers)
- Journals
- Open Forum Infectious Diseases (8 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Hepatology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Pediatric Pulmonology (1 paper)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Kajal Larson
25 papers receiving 480 citations
Peers
Comparison fields: 5 of 55
- Molecular Medicine 112
- Applied Microbiology and Biotechnology 30
- Infectious Diseases 151
- Pharmacology 134
- Critical Care and Intensive Care Medicine 25
Countries citing papers authored by Kajal Larson
This map shows the geographic impact of Kajal Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kajal Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kajal Larson more than expected).
Fields of papers citing papers by Kajal Larson
This network shows the impact of papers produced by Kajal Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kajal Larson. The network helps show where Kajal Larson may publish in the future.
Co-authors
The 25 scholars most cited alongside Kajal Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 64 | |
| 2 | 2017 | 62 | |
| 3 | 2020 | 54 | |
| 4 | 2014 | 51 | |
| 5 | 2015 | 48 | |
| 6 | 2013 | 37 | |
| 7 | 2018 | 33 | |
| 8 | 2019 | 30 | |
| 9 | 2021 | 27 | |
| 10 | 2017 | 14 | |
| 11 | 2018 | 11 | |
| 12 | 2020 | 9 | |
| 13 | 2015 | 8 | |
| 14 | 2019 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2017 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2017 | 2 |
About Kajal Larson
Kajal Larson is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 485 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers), HIV/AIDS drug development and treatment (3 papers), Cystic Fibrosis Research Advances (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Poisoning and overdose treatments (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Molecular Medicine (112 citations), Applied Microbiology and Biotechnology (30 citations), Infectious Diseases (151 citations), Pharmacology (134 citations) and Critical Care and Intensive Care Medicine (25 citations). Kajal Larson has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Edward P. Acosta, Elizabeth G. Rhee, Luzelena Caro, Adedayo Adedoyin, Matthew L. Rizk, Brian Yu, Yoshihiko Murata, Laurent Chesnel, Kun Wang and Joseph L. Kuti. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Hepatology, Journal of Antimicrobial Chemotherapy and Pediatric Pulmonology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.